A male patient who developed late-onset primary biliary cirrhosis presenting with antinuclear envelope antibodies

Modern Rheumatology

Volumn 12, Issue 3, 2002, Pages 246-249

  Miyachi, Kiyomitsu ^a   Horigome, Tuneyoshi ^b   Matsuoka, Yasuo ^c   Irimajiri, Shouichirou ^c   Shibata, Minoru ^d   Asada, Kouichi ^e   Hankins, Raleigh W ^f  

^a Keigu Clinic   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TSURUMI UNIVERSITY   (Japan)

^f Health Sciences Research Institute   (Japan)

Author keywords

Anti gp20 antibody; Anti p62 complex antibody; Antinuclear envelope antibody (ANEA); Primary biliary cirrhosis (PBC); Sj gren's syndrome (SS)

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLYCOPROTEIN; MITOCHONDRION ANTIBODY; PROTEIN P62; URSODEOXYCHOLIC ACID;

AGED; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; LIVER BIOPSY; LIVER FAILURE; LIVER INJURY; MALE; MALNUTRITION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYMPTOMATOLOGY;

EID: 0042672938     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101650200043     Document Type: Article

References (15)

1. Ruffatti A, Arslan P, Eloreani A, deSilvestro G, Calligaro A, Naccarato R, et al. Nuclear membrane staining anti-nuclear antibody in patients with primary biliary cirrhosis. J Clin Immunol 1985;5:357-61.
2. Lozano FL, Pares A, Borche L, Plana M, Gallart T, Rodes J, et al. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 1988;8:930-8.
3. Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210 kilodalton nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the glycoprotein of the nuclear pore. J Clin Invest 1990;86:279-85.
4. Nickowitz RW, Wozniak PW, Schffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994; 106:193-9.
5. Shibata M, Ueno Y, Onozuka Y, Kawaguchi N, Oda Y, Hiwatashi T, et al. Autoantibodies against nuclear envelope in patients with primary biliary cirrhosis. Int Hepatol Commun 1995;4:46-53.
6. Gadek JW, Hohenauer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 1996;110:840-7.
7. Kita K, Omata S, Horigome T. Purification and characterization of a nuclear pore glycoprotein complex containing p62. J Biochem 1993;113:377-82.
8. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973;289:674-8.
9. Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on analysis of 236 patients. Gastroenterology 1980;78:236-46.
10. Floreani A, Chiaramonte M, Fabris P, Naccarato R. Primary biliary cirrhosis in the elderly. Recenti Prog Med 1991;82:2-5.
11. Shibata M, Ouya K, Hachiya T, Tamai K, Miyachi K, Horigome T, et al. Detection of anti-gp210 antibodies in primary biliary cirrhosis by enzyme-linked immunosorbent assay with a synthesized polypeptide. In: Yamanaka M, Toda G, Tanaka T, editors. Progress in hepatology, Vol. 5. Liver and immunology. Amsterdam: Elsevier; 1999. p. 125-33.
12. Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. PBC sera recognize not only gp210 but also p62 complex proteins bearing N-acetylglucoseamine residues from rat liver nuclear envelope. Mol Biol Rep 1996;23:227-34.
13. Miyachi K, Watanabe S, Yamashiki M, Hiwatashi T, Ichida F. Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis. Am J Gastroenterol 1984;79:704-9.
14. Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, et al. Autoantibodies against a 210-kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998;13:257-65.
15. Tsuneyama K, Water JVD, Leung PS, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995;21:1031-7.